124 related articles for article (PubMed ID: 34114707)
1. Inhibition of TMPRSS4 mediated epithelial-mesenchymal transition is critically involved in antimetastatic effect of melatonin in colorectal cancers.
Oh BS; Im E; Lee HJ; Sim DY; Park JE; Park WY; Park Y; Koo J; Pak JN; Kim DH; Shim BS; Kim SH
Phytother Res; 2021 Aug; 35(8):4538-4546. PubMed ID: 34114707
[TBL] [Abstract][Full Text] [Related]
2. TMPRSS4 upregulates uPA gene expression through JNK signaling activation to induce cancer cell invasion.
Min HJ; Lee Y; Zhao XF; Park YK; Lee MK; Lee JW; Kim S
Cell Signal; 2014 Feb; 26(2):398-408. PubMed ID: 23978400
[TBL] [Abstract][Full Text] [Related]
3. TMPRSS4 induces invasion and epithelial-mesenchymal transition through upregulation of integrin alpha5 and its signaling pathways.
Kim S; Kang HY; Nam EH; Choi MS; Zhao XF; Hong CS; Lee JW; Lee JH; Park YK
Carcinogenesis; 2010 Apr; 31(4):597-606. PubMed ID: 20118200
[TBL] [Abstract][Full Text] [Related]
4. TMPRSS4 induces invasion and proliferation of prostate cancer cells through induction of Slug and cyclin D1.
Lee Y; Ko D; Min HJ; Kim SB; Ahn HM; Lee Y; Kim S
Oncotarget; 2016 Aug; 7(31):50315-50332. PubMed ID: 27385093
[TBL] [Abstract][Full Text] [Related]
5. TMPRSS4 promotes invasion, migration and metastasis of human tumor cells by facilitating an epithelial-mesenchymal transition.
Jung H; Lee KP; Park SJ; Park JH; Jang YS; Choi SY; Jung JG; Jo K; Park DY; Yoon JH; Park JH; Lim DS; Hong GR; Choi C; Park YK; Lee JW; Hong HJ; Kim S; Park YW
Oncogene; 2008 Apr; 27(18):2635-47. PubMed ID: 17968309
[TBL] [Abstract][Full Text] [Related]
6. TMPRSS4 facilitates epithelial-mesenchymal transition of hepatocellular carcinoma and is a predictive marker for poor prognosis of patients after curative resection.
Wang CH; Guo ZY; Chen ZT; Zhi XT; Li DK; Dong ZR; Chen ZQ; Hu SY; Li T
Sci Rep; 2015 Jul; 5():12366. PubMed ID: 26190376
[TBL] [Abstract][Full Text] [Related]
7. TMPRSS4 induces cancer cell invasion through pro-uPA processing.
Min HJ; Lee MK; Lee JW; Kim S
Biochem Biophys Res Commun; 2014 Mar; 446(1):1-7. PubMed ID: 24434139
[TBL] [Abstract][Full Text] [Related]
8. TMPRSS4 Upregulates TWIST1 Expression through STAT3 Activation to Induce Prostate Cancer Cell Migration.
Jianwei Z; Qi L; Quanquan X; Tianen W; Qingwei W
Pathol Oncol Res; 2018 Apr; 24(2):251-257. PubMed ID: 28466252
[TBL] [Abstract][Full Text] [Related]
9. TMPRSS4 induces cancer stem cell-like properties in lung cancer cells and correlates with ALDH expression in NSCLC patients.
de Aberasturi AL; Redrado M; Villalba M; Larzabal L; Pajares MJ; Garcia J; Evans SR; Garcia-Ros D; Bodegas ME; Lopez L; Montuenga L; Calvo A
Cancer Lett; 2016 Jan; 370(2):165-76. PubMed ID: 26546046
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of TMPRSS4 promotes tumor proliferation and aggressiveness in breast cancer.
Li XM; Liu WL; Chen X; Wang YW; Shi DB; Zhang H; Ma RR; Liu HT; Guo XY; Hou F; Li M; Gao P
Int J Mol Med; 2017 Apr; 39(4):927-935. PubMed ID: 28259959
[TBL] [Abstract][Full Text] [Related]
11. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
[TBL] [Abstract][Full Text] [Related]
12. Role of miR-541-3p/TMPRSS4 in the metastasis and EMT of hepatocellular carcinoma.
Xia YH; Ren L; Li JZ; Gao F
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10721-10728. PubMed ID: 31858539
[TBL] [Abstract][Full Text] [Related]
13. Anti-cancer activity of the novel 2-hydroxydiarylamide derivatives IMD-0354 and KRT1853 through suppression of cancer cell invasion, proliferation, and survival mediated by TMPRSS4.
Kim S; Ko D; Lee Y; Jang S; Lee Y; Lee IY; Kim S
Sci Rep; 2019 Jul; 9(1):10003. PubMed ID: 31292507
[TBL] [Abstract][Full Text] [Related]
14. Integrin-linked kinase overexpression promotes epithelial-mesenchymal transition via nuclear factor-κB signaling in colorectal cancer cells.
Shen H; Ma JL; Zhang Y; Deng GL; Qu YL; Wu XL; He JX; Zhang S; Zeng S
World J Gastroenterol; 2016 Apr; 22(15):3969-77. PubMed ID: 27099440
[TBL] [Abstract][Full Text] [Related]
15. Rubus idaeus L. reverses epithelial-to-mesenchymal transition and suppresses cell invasion and protease activities by targeting ERK1/2 and FAK pathways in human lung cancer cells.
Hsieh YS; Chu SC; Hsu LS; Chen KS; Lai MT; Yeh CH; Chen PN
Food Chem Toxicol; 2013 Dec; 62():908-18. PubMed ID: 24161487
[TBL] [Abstract][Full Text] [Related]
16. TMPRSS4: an emerging potential therapeutic target in cancer.
de Aberasturi AL; Calvo A
Br J Cancer; 2015 Jan; 112(1):4-8. PubMed ID: 25203520
[TBL] [Abstract][Full Text] [Related]
17. Inhibitor of growth 4 suppresses colorectal cancer growth and invasion by inducing G1 arrest, inhibiting tumor angiogenesis and reversing epithelial-mesenchymal transition.
Qu H; Yin H; Yan S; Tao M; Xie Y; Chen W
Oncol Rep; 2016 May; 35(5):2927-35. PubMed ID: 26936485
[TBL] [Abstract][Full Text] [Related]
18. TMPRSS4 correlates with colorectal cancer pathological stage and regulates cell proliferation and self-renewal ability.
Huang A; Zhou H; Zhao H; Quan Y; Feng B; Zheng M
Cancer Biol Ther; 2014 Mar; 15(3):297-304. PubMed ID: 24335200
[TBL] [Abstract][Full Text] [Related]
19. Physcion inhibits the metastatic potential of human colorectal cancer SW620 cells in vitro by suppressing the transcription factor SOX2.
Han YT; Chen XH; Gao H; Ye JL; Wang CB
Acta Pharmacol Sin; 2016 Feb; 37(2):264-75. PubMed ID: 26707141
[TBL] [Abstract][Full Text] [Related]
20. TMPRSS4 promotes invasiveness of human gastric cancer cells through activation of NF-κB/MMP-9 signaling.
Jin J; Shen X; Chen L; Bao LW; Zhu LM
Biomed Pharmacother; 2016 Feb; 77():30-6. PubMed ID: 26796262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
